Although providers can prescribe medications for off-label use, insurance coverage for a specific indication ideally means patients can afford and access the medication and that sufficient evidence supports its use for that indication
In 2004, researchers conducted a meta-analysis of 61 randomized controlled trials evaluating GLP-1 RAs, sodium-glucose co-transporter-2 inhibitors (SGLT2i), dipeptidyl peptidase 4 inhibitors (DPP-4i) and didnt find an increased risk of diabetic retinopathy events with GLP-1 RAs or any of the other classes of antihyperglycemic medications
Find a Provider Find a provider who specializes in sexual medicine in your area
Effect of Glucagon-like Peptide 1 on Salivary Gland Hypofunction in Diabetic Db/Db Mice. Journal of Biomedical and Translational Research , vol
Monitor your progress systematically Track weight, body measurements, energy levels, appetite changes, side effects, and any relevant lab values throughout your protocol